# Varex Imaging Corporation (VREX) Stock Analysis: Exploring the 73% Potential Upside

- Link: https://www.directorstalkinterviews.com/varex-imaging-corporation-vrex-stock-analysis-exploring-the-73-potential-upside/4121247696
- Published: 2026-04-02T10:09:29+01:00
- Author: Madison Wilson

Varex Imaging Corporation (NASDAQ: VREX), a key player in the healthcare sector 
specializing in medical devices, presents a compelling investment case with a notable
potential upside of 73.26%. Headquartered in Salt Lake City, Utah, Varex designs
and manufactures X-ray imaging components for both medical and industrial applications.
This dual-segment approach allows the company to cater to a broad range of applications
from CT and mammography in healthcare to non-destructive testing and cargo inspection
in industrial settings.

Currently trading at $10.62, Varex Imaging’s stock price has experienced a period
of volatility, with a 52-week range of $6.88 to $14.36. Despite this, the company
has garnered positive sentiment among analysts, with four buy ratings and a single
hold rating. The consensus target price, averaging $18.40, suggests significant 
upside potential, providing an attractive opportunity for investors willing to navigate
the inherent risks.

The company’s financial metrics reveal a mixed performance. While the revenue growth
at 4.90% indicates a positive trajectory, challenges remain evident with a negative
EPS of -1.64 and a return on equity of -12.90%. These figures reflect operational
hurdles that the company is working to overcome. Notably, Varex does not currently
offer a dividend, which aligns with its strategy of reinvesting earnings to fuel
growth and innovation in its product offerings.

Varex’s valuation metrics provide additional insights into its market position. 
The forward P/E ratio stands at 10.08, signaling potential value relative to future
earnings expectations. However, the absence of trailing P/E, PEG, and other valuation
ratios suggests investors need to exercise caution and consider the company’s growth
prospects alongside its current financial health.

Technical indicators paint a cautious picture, with the stock trading below both
its 50-day and 200-day moving averages. The Relative Strength Index (RSI) of 25.10
indicates that the stock is currently oversold, which might present a buying opportunity
for contrarian investors. The MACD and Signal Line both trending negatively further
confirm the bearish sentiment in the short term.

For investors considering Varex Imaging Corporation, it’s essential to weigh the
potential upside against the operational challenges and current market sentiment.
The company’s strategic focus on expanding its market share in medical and industrial
imaging components, coupled with a broad geographical footprint, provides a robust
foundation for future growth. As Varex continues to innovate and adapt to market
demands, its performance metrics and stock valuation are likely to improve, offering
long-term gains for patient investors.

Share on: